Roger Sidhu
Chief Executive Officer presso Treadwell Therapeutics, Inc.
Patrimonio netto: 2 419 $ in data 31/03/2024
Profilo
Roger Sidhu is currently the Chief Executive Officer at Treadwell Therapeutics, Inc. He previously held positions as the Global Product GM-Translational Sciences at Amgen, Inc. from 2016 to 2017, Chief Medical Officer, Executive VP & Head-R&D at Roivant Sciences Ltd.
from 2020 to 2021, Vice President-Clinical Development at Kite Pharma, Inc. from 2018 to 2020, Chief Medical Officer at Cell Design Labs, Inc. from 2017 to 2018, and Chief Medical Officer at Eterna Therapeutics, Inc. from 2021 to 2023.
Dr. Sidhu obtained a doctorate degree from Queen's University and an undergraduate degree from the University of Alberta.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ETERNA THERAPEUTICS INC.
0.02% | 26/04/2023 | 1 008 ( 0.02% ) | 2 419 $ | 31/03/2024 |
Posizioni attive di Roger Sidhu
| Società | Posizione | Inizio |
|---|---|---|
Treadwell Therapeutics, Inc.
 Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | Chief Executive Officer | 08/12/2023 |
Precedenti posizioni note di Roger Sidhu
| Società | Posizione | Fine |
|---|---|---|
| ETERNA THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 31/01/2023 |
| ROIVANT SCIENCES LTD. | Chief Tech/Sci/R&D Officer | 01/01/2021 |
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | 01/01/2020 |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Chief Tech/Sci/R&D Officer | 01/01/2018 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2017 |
Formazione di Roger Sidhu
| Queen's University | Doctorate Degree |
| University of Alberta | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| ROIVANT SCIENCES LTD. | Health Technology |
| Aziende private | 4 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Cell Design Labs, Inc.
Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Health Technology |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | Health Technology |
| Eterna Therapeutics, Inc. |
- Borsa valori
- Insiders
- Roger Sidhu
